AIFM2 and pancreatic neoplasm: Similarly, pancreatic cancer cells with KRAS mutations exhibit increased vulnerability to ferroptosis due to elevated levels of ferroptosis suppressor protein 1 (FSP1), which protects against lipid peroxidation [40].